Mass Balance and Pharmacokinetics Study of Derazantinib in Healthy Male Subjects
Clinical trial NCT04098692 · COMPLETED
Trial details
- NCT number
- NCT04098692
- Sponsor
- Basilea Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-08
- Primary completion
- 2019-11-18
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.